Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Ozempic is FDA-approved for the treatment of type 2 diabetes and for certain cardiovascular risk reduction indications, while Wegovy is FDA-approved for chronic weight management in adults who meet specific body mass index (BMI) criteria
Anyone with serious medical conditions should discuss risks with their physician before starting treatment
Clinical trials have reported that most participants tolerated up to 12 mg per week with minimal adverse events when titrated correctly
The dedicated cardiovascular outcomes trial (TRIUMPH-Outcomes), enrolling around 10,000 participants with established cardiovascular disease, chronic kidney disease, or high CV risk, is not expected to report until 2027 at the earliest [11]
US$ 22.87
US$ 28.19
US$ 21.01
